Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

In today's Asking Eric column, R. Eric Thomas responds to someone who is disappointed their friends didn't notice their ...

Now, after gaining all that weight back due to not being able to continually and severely restrict my diet, I am using ...

The incidence of obesity and diabetes is rising in India, the world’s most populous country, which also ranks among the worst ...

Dear Eric: Regarding your response to “What to Say”, who didn’t know how to address a friend’s Ozempic weight loss: ...

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...

As weight-loss drugs like semaglutide and tirzepatide dominate global headlines, a new nationwide survey shows that 87 per cent of Indian adults beli ...

Once-weekly cagrilintide–semaglutide combination therapy produced unprecedented weight reductions in adults with overweight or obesity, with 60% achieving ≥20% loss and strong cardiometabolic benefits ...

Earlier this week, semaglutide drugs Ozempic and Wegovy were made available for prescription in New Zealand. Semaglutide ...

I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

Anyone using weight loss injections, either through the NHS or privately, has been issued a major warning when it comes to ...